HER2 (4B5) breast cancer algorithm by navify Digital Pathology
Product TypeAssay Kit
Regulatory StatusRUO

Key takeaways
HER2 (4B5) breast cancer algorithm by navify Digital Pathology is a product in the Histology & IHC category, manufactured by Roche Diagnostics. Listed regulatory status: RUO (as reported by the manufacturer).
- Applications: Oncology Markers
Classification
- Category
- Histology & IHC
- Product Type
- Assay Kit
Application
- Application Area
- Oncology Markers
Regulatory Status
RUO
Reported from manufacturer sources and not independently verified.
Review and references
Compiled from public manufacturer materials and regulatory sources. Not independently verified and not reviewed by a named clinician.
2026-10-16
2026-11-01
availability varies
